For Medical Professionals

Industry News

Mayo Clinic researchers identify methylated DNA markers -- noninvasive cancer screen
4/24/2015

A team of Mayo Clinic researchers has succeeded in identifying the source of cancer in patients' gastrointestinal tracts by analyzing DNA markers from tumors.

Childhood cancer survivors more likely to claim social security support as adults
4/24/2015

Children with cancer have a good chance of surviving the disease--today more than 80 percent survive because of advances in treatment and care.

Coffee 'could halve breast cancer recurrence' in tamoxifen-treated patients
4/23/2015

Consuming at least two cups of coffee a day could halve the risk of recurrence in patients diagnosed with breast cancer who are treated with tamoxifen, according to a new study.

Frequent indoor tanning among New Jersey teens shows correlation with smoking and social media use
4/23/2015

Research from Rutgers Cancer Institute of New Jersey and Rutgers School of Public Health shows more than a third of New Jersey high school students who engage in indoor tanning do so frequently and...

Phase III study: Pembrolizumab demonstrates superior survival, progression free survival and overall response rate compared to Ipilimumab
4/23/2015

MSD (known as Merck & Co Inc. in the United States and Canada) has announced results from the randomised, pivotal Phase 3 study, KEYNOTE-006 which compared pembrolizumab to ipilimumab in patients...

IMBRUVICA longer-term follow-up data demonstrate durable responses, including complete responses, in patients with chronic lymphocytic leukemia
4/23/2015

Pharmacyclics, Inc. has announced that IMBRUVICA® (ibrutinib) follow-up data in treatment-naive (TN) and relapsed/refractory (R/R) patients with chronic lymphocytic leukemia or small...

UF Health Proton Therapy Institute opens randomized clinical trial for glioblastoma
4/23/2015

Adults who have a recent diagnosis of glioblastoma, the most common primary brain tumor, may be eligible to enroll in a national randomized clinical trial at the University of Florida Health Proton...

Investigational brain cancer vaccine produces strong immunological response
4/23/2015

A first-of-its kind cancer vaccine, SurVaxM, has demonstrated safety and tolerability in patients with recurrent or progressive malignant brain tumors, according to results of a phase I study...

Inflammation-cancer feedback loop discovery is a step toward better cancer drugs
4/23/2015

New findings hidden within the complex machinery behind the vicious cycle of chronic inflammation and cancer have been presented by researchers from the University of Pittsburgh Cancer Institute...

The Association for Molecular Pathology compiles current research on liquid biopsy
4/23/2015

The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular diagnostic professionals, has published a special article in The Journal of Molecular...